Rapid identification of viral infections and specific variants in patient samples requires a simple and multiplexed RNA detection method that does not rely on DNA sequencing.
Although recent direct detection assays based on CRISPR–Cas13a offer rapid RNA detection by avoiding reverse transcription and DNA amplification required of gold-standard PCR assays, these assays are not easily multiplexed to detect multiple viruses or variants without dividing the sample into separate reactions.
Here we show that Cas13a acting on single-target RNAs exhibits variable nuclease activity that depends on the interaction between the target RNA and crRNA.
To exploit this feature for multiplexed detection, we devised a crRNA modification strategy that enables programmable tuning of Cas13a’s nuclease enzymatic rates.
Using a droplet-based Cas13a assay, we demonstrate that kinetic signatures can be harnessed to differentiate among respiratory viruses and SARS-CoV-2 variants in contrived and clinical samples.
This kinetic barcoding strategy can be extended to additional RNA targets through simple modification of crRNAs.
Nat Biomed Eng. 2026 Mar 31.
